Literature DB >> 21183657

Pcsk6 mutant mice exhibit progressive loss of ovarian function, altered gene expression, and formation of ovarian pathology.

Michelle L Mujoomdar1, Laura M Hogan, Albert F Parlow, Mark W Nachtigal.   

Abstract

Bioactivation of precursor proteins by members of the proprotein convertase (PC) family is essential for normal reproduction. The Pcsk6 gene is a member of the PC family that is expressed in numerous ovarian cell types including granulosa cells and oocytes. We hypothesized that loss of PCSK6 would produce adverse effects in the mouse ovary. Mice incapable of expressing PCSK6 (Pcsk6(tm1Rob)) were obtained, and reproductive parameters (serum hormones, whelping interval, estrus cyclicity, and fertility) were compared to Pcsk6(+/+) mice. While Pcsk6(tm1Rob) female mice are fertile, they manifest reduced reproductive capacity at an accelerated rate relative to Pcsk6(+/+) mice. Reproductive senescence is typically reached by 9 months of age and is correlated with loss of estrus cyclicity, elevated serum FSH levels, and gross alterations in ovarian morphology. A wide range of ovarian morphologies were identified encompassing mild, such as an apparent reduction in follicle number, to moderate--ovarian atrophy with a complete absence of follicles--to severe, manifesting as normal ovarian structures replaced by benign ovarian tumors, including tubulostromal adenomas. Targeted gene expression profiling highlighted changes in RNA expression of molecules involved in processes such as steroidogenesis, gonadotropin signaling, transcriptional regulation, autocrine/paracrine signaling, cholesterol handling, and proprotein bioactivation. These results show that PCSK6 activity plays a role in maintaining normal cellular and tissue homeostasis in the ovary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183657     DOI: 10.1530/REP-10-0451

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  6 in total

1.  Pcsk6 Deficiency Promotes Cardiomyocyte Senescence by Modulating Ddit3-Mediated ER Stress.

Authors:  Wenxing Zhan; Liping Chen; Hongfei Liu; Changkun Long; Jiankun Liu; Shuangjin Ding; Qingyu Wu; Shenghan Chen
Journal:  Genes (Basel)       Date:  2022-04-18       Impact factor: 4.141

2.  Relative expression of proprotein convertases in rat ovaries during pregnancy.

Authors:  Simon Cm Kwok; Damayanti Chakraborty; Michael J Soares; Guoli Dai
Journal:  J Ovarian Res       Date:  2013-12-11       Impact factor: 4.234

3.  Gene expression patterns in granulosa cells and oocytes at various stages of follicle development as well as in in vitro grown oocyte-and-granulosa cell complexes.

Authors:  Yasuhisa Munakata; Ryoka Kawahara-Miki; Shogo Shiratsuki; Hidetaka Tasaki; Nobuhiko Itami; Koumei Shirasuna; Takehito Kuwayama; Hisataka Iwata
Journal:  J Reprod Dev       Date:  2016-04-22       Impact factor: 2.214

4.  Evolutionary and biomedical insights from a marmoset diploid genome assembly.

Authors:  Chentao Yang; Yang Zhou; Stephanie Marcus; Giulio Formenti; Lucie A Bergeron; Zhenzhen Song; Xupeng Bi; Juraj Bergman; Marjolaine Marie C Rousselle; Chengran Zhou; Long Zhou; Yuan Deng; Miaoquan Fang; Duo Xie; Yuanzhen Zhu; Shangjin Tan; Jacquelyn Mountcastle; Bettina Haase; Jennifer Balacco; Jonathan Wood; William Chow; Arang Rhie; Martin Pippel; Margaret M Fabiszak; Sergey Koren; Olivier Fedrigo; Winrich A Freiwald; Kerstin Howe; Huanming Yang; Adam M Phillippy; Mikkel Heide Schierup; Erich D Jarvis; Guojie Zhang
Journal:  Nature       Date:  2021-04-28       Impact factor: 49.962

Review 5.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

6.  Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.

Authors:  Rémi Longuespée; Frédéric Couture; Christine Levesque; Anna Kwiatkowska; Roxane Desjardins; Sandra Gagnon; Daniele Vergara; Michelle Maffia; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2014-05-09       Impact factor: 4.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.